IVERIC bio, Inc. Profile Avatar - Palmy Investing

IVERIC bio, Inc.

IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 compri…
Biotechnology
US, Parsippany [HQ]
ISEE/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ISEE's Analysis
CIK: 1410939 CUSIP: 46583P102 ISIN: US46583P1021 LEI: - UEI: -
Secondary Listings
ISEE has no secondary listings inside our databases.